FDA Import Refusal 799-1919971-7/10003/1 — Logos Pharma

Logos Pharma — FEI 3011433465

The FDA refused shipment 799-1919971-7/10003/1 from Logos Pharma (India) on Feb 4, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.